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OBJECTIVE — To examine the recent suggestion that impaired fasting glucose may protect
against depression, whereas a diagnosis of diabetes might then result in depression.
RESEARCH DESIGN AND METHODS — Cross-sectional analysis of 4,228 adults
(meanage60.7years,73.0%men)whounderwentoralglucosetolerancetestingandcompleted
the Center for Epidemiologic Studies Depression scale (CES-D).
RESULTS — After adjustment for demographic factors, health behaviors, and clinical mea-
surements (BMI, waist circumference, lipid proﬁle, and blood pressure), there was a U-shaped
associationbetweenfastingglucoseanddepression(Pcurve0.001),withelevatedCES-Datlow
and very high glucose levels. This ﬁnding was replicable with 2-h postload glucose (P  0.11)
and A1C (P  0.007).
CONCLUSIONS — The U-shaped association between blood glucose and CES-D, with the
lowestdepressionriskseenamongthoseinthenormoglycemicrangeofA1C,didnotsupportthe
hypothesized protective effect of hyperglycemia.
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T
heassociationbetweentype2diabe-
tesanddepression,bothmajorpub-
lic health challenges, remains
unclear (1–8). In a recent U.S. report,
people with type 2 diabetes had an in-
creased risk of depressive symptoms,
whereas in nondiabetic individuals
higher impaired fasting glucose (IFG) ap-
peared to confer protection against de-
pression (8). Although an increased
prevalenceofdepressioninpeoplereceiv-
ing a diagnosis of a pernicious chronic
disease such as type 2 diabetes is perhaps
unsurprising, the apparent counterintui-
tive protective effect of IFG warrants fur-
ther scrutiny.
RESEARCH DESIGN AND
METHODS— Data were from the
Whitehall II study (9). In the 2003 and
2004 data collection phase, 4,228 men
and women aged 50–74 years completed
a depression questionnaire and, if with-
out known diabetes, underwent an oral
glucose tolerance test (OGTT). Venous
blood samples were taken after at least
8-h fasting, before OGTT, and at 2-h pos-
tadministrationofa75gglucosesolution.
Blood glucose was measured using the
glucose oxidase method (10) on a YSI
MODEL 2300 STAT PLUS Analyzer (YSI
Corporation, Yellow Springs, OH; mean
coefﬁcient of variation [CV] 1.4–3.1%)
(11). Diabetes was deﬁned by a fasting
glucose 7.0 mmol/l, a 2-h postload glu-
cose 11.1 mmol/l, reported doctor-
diagnosed diabetes, or use of diabetes
medication (12). In nondiabetic partici-
pants,weclassiﬁedmoderatehyperglyce-
mia as IFG (fasting glucose 5.6–6.9
mmol/l) and impaired glucose tolerance
(IGT) (2-h postload glucose 7.8–11.0
mmol/l) (12). A1C was measured in
whole blood with a calibrated high-
performance liquid chromatography sys-
tem (CV 0.8%).
Depressive symptoms were assessed
withtheCenterforEpidemiologicStudies
Depression scale (CES-D) summary score
(13), a measure that has been validated
among diabetic patients (14). Ethnicity
(Caucasian or non-Caucasian), BMI
(weight in kilograms divided by height in
meters squared [kg/m
2]), waist circum-
ference (cm), systolic and diastolic blood
pressure (mmHg), HDL and LDL choles-
terol (mmol/l), triglycerides (mmol/l),
current smoking (yes/no), alcohol con-
sumption(none,1–3unitsperday,or3
units per day), and physical inactivity
(2.5 h moderate and 1 h vigorous ex-
ercise per week) were measured accord-
ing to standardized protocols.
Statistical analyses are based on be-
tween 3,945 (93% of the 4,228) and
4,228 (100%) of the eligible participants
because there were missing data for some
of the various glucose parameters. Values
for triglycerides were log transformed
prior to analyses because of skewed dis-
tribution. We used linear regression anal-
ysis to model the associations of IFG and
IGT with the CES-D score. The shape of
the associations between fasting glucose,
postload glucose, A1C, and CES-D were
studied by treating all these measures as
continuous variables. To test for curvilin-
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measures was added to an equation con-
taining the linear term. The models were
adjusted for age, sex, ethnicity, and clinical
characteristics (BMI, waist circumference,
systolic and diastolic blood pressure, HDL
andLDLcholesterol,triglycerides,smoking
status, alcohol consumption, and physical
activity). Subsidiary analyses examined
these associations in subgroups and in the
whole cohort with glucose levels measured
repeatedly (in 1997–1999 and in 2003–
2004) and with a dichotomized CES-D
score (16 vs. 16). The statistical tests
were performed with STATA version 10.1.
RESULTS— Of the 4,228 participants,
2,038 (73.0%) were men and 3,895
(92.1%) Caucasian. Mean  SD age was
60.76.0years,andthelevelsofclinical
characteristics were 128  17 and 74 
10 mmHg for systolic and diastolic blood
pressure, respectively, 1.6  0.4 mmol/l
for HDL cholesterol, 3.58  1.9 mmol/l
for LDL cholesterol, 26.7  4.4 kg/m
2 for
BMI, and 94.2  10.7 cm (men) and
84.3  13.0 cm (women) for waist cir-
cumference. For triglycerides, median
(interquartile range) was 1.2 (0.8–1.6)
mmol/l. Of the participants, 7.9% were
current smokers, 16.0% were physically
inactive, 17.8% consumed more than 3
units of alcohol per day, and 16.2% did
not consume alcohol regularly. Overall
CES-D mean score was 9.9  6.6.
Fasting glucose
MeanSDforfastingglucosewas5.55
1.51mmol/l.Comparedwithparticipants
with normal fasting glucose (n  3,038;
CES-D 9.9  6.7), those with IFG (n 
735)showedamarginallyreducedCES-D
score (9.0  6.1; P  0.05), whereas
those with diabetes (n  455) showed an
elevated CES-D score (11.2  7.0; P 
0.002) after taking into account age, sex,
and ethnicity. As shown in Fig. 1A, there
was a U-shaped association between fast-
ing glucose and CES-D (Pcurve  0.001
after adjustment for age, sex, and ethnic-
ity; n  3,986), with elevated CES-D val-
ues at glucose levels 4.5 and 9.0
mmol/l. The curvilinear trend was robust
to additional adjustment for clinical char-
acteristics (P  0.001).
Postload glucose
Mean  SD for postload glucose was
6.38  2.09 mmol/l. IGT (n  423;
CES-D 9.49  6.58) was not associated
with CES-D (P  0.75). However, there
wasaU-shapedassociationbetweenpost-
load glucose and CES-D (Fig. 1B; n 
3,455; Pcurve  0.05 after adjustment for
age, sex, and ethnicity; Pcurve  0.11 after
additional adjustment for clinical char-
acteristics).
A1C
Mean  SD for A1C was 5.36  0.73%.
Again,acurvilinearassociationwithCES-D
wasevident(P0.04;n4,160;Fig.1C).
The lowest CES-D scores were between
Figure 1—Age-, sex, and ethnicity-adjusted associations of fasting glucose (A), 2-h postload
glucose (B), and A1C (C) with self-reported depressive symptoms assessed with CES-D.
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age-, sex-, and ethnicity-adjusted model).
The curvilinear trend remained after addi-
tional adjustment for all clinical character-
istics (P  0.007).
Subsidiary analyses
There were no differences in the U-
shaped associations of the three glucose
measures with CES-D between men and
women or between Caucasian and non-
Caucasian participants (all Pinteraction 
0.15–0.74). Using the average of re-
peated fasting and postload glucose
measurements as exposure variables rep-
licated the U-shaped associations (Pcurve 
0.01). With the dichotomised CES-D
score, the U-shaped trend reached statis-
tical signiﬁcance for repeatedly measured
fasting glucose (Pcurve  0.02), but for
the other glucose measures conventional
statistical signiﬁcance was not met (Pcurve
 0.09–0.26). (See supplemental Table
1, available in an online appendix at
http://care.diabetesjournals.org/cgi/
content/full/ dc09-0716/DC1.)
CONCLUSIONS — Ourresultsshow
slightly lower levels of depressive symp-
tomsamongnondiabeticindividualswith
IFG. However, this ﬁnding was generated
by a U-shaped association between fast-
ing glucose and CES-D with elevated de-
pression scores seen at both ends of the
glucose distribution, a ﬁnding that was
replicated for 2-h postload glucose and
A1C. Although low depression scores
were observed both at normal and pre-
diabetic ranges of fasting and postload
glucose, ﬁndings from long-term glucose
levels (A1C) suggested that normoglyce-
micindividualshadthelowestdepression
risk. Our results do not support a protec-
tive effect of hyperglycemia against de-
pressive symptoms. Future research
should examine whether our ﬁndings are
generalizable to other populations and
whether they are applicable to clinical
depression.
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